Part 8 of Title 42 of the Code of Federal Regulations (CFR) includes the regulations that guide opioid treatment programs (OTPs), which became effective in 2001. The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), revised these regulations and released the final rule in February 2024. The revisions amended the regulations with the intent to increase access to lifesaving, evidence-based medications for opioid use disorder (MOUD) and to advance treatment retention through the promotion of person-centered and compassionate interventions. These revised rules went into effect on April 2, 2024.

This is a notice of the opportunity to comment on a DRAFT regulatory action to amend the Rules and Regulations for Licensing Providers by the Department of Behavioral Health and Developmental Services (12VAC35-105) (the “Licensing Regulations”): 

DRAFT Chapter 105 Amendments to Align with Federal Updates Regarding Medications for Opioid Use Disorder (MOUD)

Anyone wishing to submit written comments for the public comment file may do so through the Public Comment Forums feature of the Virginia Regulatory Town Hall at the link above. Comments may also be submitted by mail, email, or fax to Susan Puglisi, Regulatory Research Specialist, DBHDS Office of Regulatory Affairs, Division of Provider Management, P.O. Box 1797, Room 411, Richmond, VA 23218-1797, susan.puglisi@dbhds.virginia.gov, and fax (804) 371-4609. In order to be considered, comments must be received by 11:59 pm on the last day of the public comment period (October 24, 2024).